Human Papillomavirus (HPV) is a sexually transmitted virus that can cause various types of cancer, including cervical cancer. HPV-16 is one of the high-risk strains of HPV that is responsible for causing about 50% of all cervical cancers worldwide. Hematology and oncology research have been focusing on HPV-16 for quite some time now, as the virus also plays a role in the development of other cancers, such as oropharyngeal, vaginal, vulvar, anal, and penile cancers. HPV-16 infects the cells present in the mucous membrane and leads to the formation of abnormal cells. These cells can undergo further mutations and turn into cancer cells, which can then spread to different parts of the body if left untreated. Research has shown that HPV-16 can also affect the immune system, making it harder for the body to fight off other infections and diseases. This has led to the development of vaccines that can protect against HPV-16 and other high-risk strains of the virus. Hematology and oncology researchers are working on developing better tests and treatments for HPV-related cancers. Some treatments being studied include immunotherapy, chemotherapy, and targeted therapy. In conclusion, HPV-16 is a high-risk strain of HPV that can lead to the development of various types of cancers. Hematology and oncology research is dedicated to finding better ways to diagnose, treat and prevent HPV-related cancers through various interventions.

From: Hematology Research and Oncology Research

Related Article For "HPV-16"

About (1) results

Editor-in-chief: Krzysztof Roszkowski, Department of Oncology F. Lukaszczyk Oncology Center Nicolaus Copernicus University
Publication Type: Open Access Journal
Description: Hematology is a branch of medicine concerning the study of blood, the blood-forming organs, and blood diseases. The word "heme" comes from the Greek for blood. Oncology is a branch of medicine that deals with prevention, diagnosis and treatment of cancer. It is very important for oncologists to keep updated of the latest advancements in oncology.